Eli Lilly’s .25B acquisition of Kelonia Therapeutics caps startup’s tortuous ride

Eli Lilly’s $3.25B acquisition of Kelonia Therapeutics caps startup’s tortuous ride

Eli Lilly is spending $3.25 billion to accumulate Kelonia Therapeutics, a small biotech firm growing cell therapies for most cancers and autoimmune ailments, the businesses introduced Monday.  Lilly might pay extra if Kelonia achieves specified scientific, regulatory, and business milestones.  The acquisition is a boon for the small startup, which has subsisted on $60 million…

Read More
Thunder set to unleash splashy trade acquisition as injury report sidelines everyone

Thunder set to unleash splashy trade acquisition as injury report sidelines everyone

After formally clinching homecourt advantage throughout the entire postseason for the third consecutive yr, the OKC Thunder are seemingly giving their core rotation some much-needed relaxation forward of what’s hoped to be a repeat championship run. Heading into Friday’s matchup in opposition to the Denver Nuggets, Oklahoma City has ruled out a total of 10…

Read More